Acoustic structure of seat back
    5.
    发明授权
    Acoustic structure of seat back 失效
    座椅靠背的声学结构

    公开(公告)号:US07159938B1

    公开(公告)日:2007-01-09

    申请号:US11178506

    申请日:2005-07-12

    申请人: Mitsuru Shiraishi

    发明人: Mitsuru Shiraishi

    IPC分类号: A47C7/62

    摘要: An acoustic structure of seat back in which speaker units are provided in a padding of the seat back. The padding includes: a frontal backrest surface area which is recessed backwardly of the seat back; and securing holes formed in that frontal backrest surface area. An enclosure of each speaker unit, in which each speaker is securely accommodated, is secured in each of the securing holes. A sound-conductive cushion element is juxtaposed on the foregoing recessed frontal backrest surface area of padding so as to lie on a frontal side of each of the speaker units. The sound-conductive cushion element may be of a network structure to not only provide an improved back support touch, but also achieve an improved conductivity of sounds from the speaker units to a user's back portion. Those padding and sound-conductive cushion element are covered with a trim cover assembly.

    摘要翻译: 扬声器单元设置在座椅靠背的衬垫中的座椅靠背的声学结构。 该衬垫包括:前座椅靠背表面区域,其位于座椅靠背的后方; 并且固定在该正面靠背表面区域中形成的孔。 每个扬声器单元的围绕每个扬声器被牢固地容纳在每个扬声器单元的每个固定孔中。 导电缓冲元件与前述凹进的前侧靠背表面区域并列放置,以便位于每个扬声器单元的正面上。 导电缓冲元件可以是网络结构,不仅提供改进的后支撑触摸,而且还实现从扬声器单元到用户的后部的改进的声音导电性。 那些填充和导电的缓冲元件被一个装饰罩组件覆盖。

    Acrylamide derivative, process for producing the same, and use
    6.
    发明申请
    Acrylamide derivative, process for producing the same, and use 审中-公开
    丙烯酰胺衍生物,其制造方法和用途

    公开(公告)号:US20060160864A1

    公开(公告)日:2006-07-20

    申请号:US10544275

    申请日:2004-02-02

    CPC分类号: C07D213/73

    摘要: A compound represented by the formula: wherein R1 is a 5- or 6-membered ring; R3 is a hydrogen atom, a lower alkyl group or a lower alkoxy group; R7 and R8 are each a hydrogen atom or a lower alkyl group; Z1 is another 5- or 6-membered aromatic ring; Z2 is a group represented by -Z2a-W1-Z2b- [wherein Z2a and Z2b are each O, S(O)m (wherein m is 0, 1 or 2), an imino group or a bond, and W1 is an alkylene chain]; X is CR (wherein R is a hydrogen atom, a lower alkyl group, a lower alkoxy group, an acyl group, or R and adjacent R4 may form a 5- or 6-membered alicyclic heterocyclic group) or N; R4 is NR5R6 (wherein R5 and R6 are each a hydrogen atom, a hydrocarbon group, a heterocyclic group or an acyl group), or R5 and R6 are bonded to each other to form a heterocyclic group of NR5R6; and R2 is (1) an amino group which may be a quaternary ammonium or oxide, (2) a nitrogen-containing heterocyclic group which may contain a sulfur atom or an oxygen atom as the ring-constituting atom, in which the nitrogen atom may be converted to a quaternary ammonium or an oxide, or the like; or a salt thereof. The compound has excellent CCR5 antagonistic activity and thus is useful as a prophylactic and/or therapeutic medicine for HIV infection into human peripheral blood monocyte, especially for AIDS.

    摘要翻译: 由下式表示的化合物:其中R 1是5或6元环; R 3是氢原子,低级烷基或低级烷氧基; R 7和R 8各自为氢原子或低级烷基; Z 1是另一个5或6元芳环; Z 2是由-Z 2a表示的基团,其中Z 2a和Z 2b各自为O,S(O)m(其中m为0,1或2),亚氨基或键, 和W 1是亚烷基链]; X是CR(其中R是氢原子,低级烷基,低级烷氧基,酰基或R和相邻的R 4)可以形成5-或6-元脂环族杂环基 )或N; R 4是NR 5 R 6(其中R 5和R 6)是 各自为氢原子,烃基,杂环基或酰基)或R 5和R 6彼此键合以形成NR的杂环基 5< 5> 6< 6> 和R 2是(1)可以是季铵或氧化物的氨基,(2)可以含有硫原子或氧原子的含氮杂环基作为环的构成 原子,其中氮原子可以转化成季铵或氧化物等; 或其盐。 该化合物具有优异的CCR5拮抗活性,因此可用作HIV感染人外周血单核细胞,特别是用于艾滋病的预防和/或治疗药物。